Provenance du réseau au premier degré de Örn Almarsson
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
Lyndra Therapeutics, Inc.
 Lyndra Therapeutics, Inc. Packaged SoftwareTechnology Services Lyndra Therapeutics, Inc. develops software technology for oral drug formulations. It offers pharmacology, therapeutic impact, reduced pill burden, and reduced care giver burden. The company was founded by Amy W. Schulman, Carlo Giovanni Traverso, Andrew Bellinger, and Robert S. Langer Jr. in 2015 and is headquartered in Watertown, MA.
6
| Holding Company | Packaged Software | 6 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Örn Almarsson via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
| AMERICAN INTERNATIONAL GROUP, INC. | Multi-Line Insurance | Chief Investment Officer Corporate Officer/Principal | |
| ALSERES PHARMACEUTICALS, INC. | Medical Specialties | Director of Finance/CFO | |
| CURIS, INC. | Biotechnology | Director of Finance/CFO | |
| JPMORGAN CHASE & CO. | Major Banks | Treasurer | |
JPMorgan Securities LLC
 JPMorgan Securities LLC Investment ManagersFinance JPMorgan Securities LLC (JPMS) is a securities brokerage firm headquartered in New York City. The firm was founded in 1985 and is a subsidiary of JPMorgan Broker-Dealer Holdings, Inc., ultimately held by JPMorgan Chase & Co., Inc. (NYSE: JPM). JPMS provides research on fixed income, credit, derivatives, emerging markets, foreign exchange, structured finance, technical analysis and bond indices. Their equity analysts cover equities throughout North America, EMEA, Asia/Pacific and the emerging markets. The firm's fixed income team formulates trading and portfolio recommendations for investors in global bonds and other fixed-income markets based on valuations, analytics and market dynamics. | Investment Managers | Corporate Officer/Principal | |
| AQUESTIVE THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
| Dartmouth College | College/University | Undergraduate Degree | |
| Indiana University | College/University | Undergraduate Degree | |
| The University of Chicago | College/University | Masters Business Admin | |
| The Johns Hopkins University | College/University | Graduate Degree | |
| Union University | College/University | Undergraduate Degree | |
| Zurich Financial Services Ltd. | Finance/Rental/Leasing | Chief Operating Officer | |
| GAMIDA CELL LTD. | Pharmaceuticals: Major | Chief Executive Officer | |
| RELYPSA INC | Pharmaceuticals: Major | Corporate Officer/Principal | |
Kidder, Peabody & Co., Inc.
 Kidder, Peabody & Co., Inc. Investment Banks/BrokersFinance Kidder, Peabody & Co., Inc. provides security brokerage services. The private company is based in Buffalo, NY and has subsidiaries in Switzerland. The company was founded by Thomas W. Ostrander. | Investment Banks/Brokers | Corporate Officer/Principal | |
AlloCure, Inc.
 AlloCure, Inc. BiotechnologyHealth Technology AlloCure, Inc. develops cell therapies for the treatment of kidney diseases. It engages in developing allogeneic mesenchymal stem cell therapy for acute kidney injury. The company was founded in 2008 and is headquartered in Burlington, MA. | Biotechnology | Director of Finance/CFO | |
Zurich Capital Markets, Inc.
 Zurich Capital Markets, Inc. Financial ConglomeratesFinance Part of Zurich Insurance Group AG, Zurich Capital Markets, Inc. is a company based in New York, NY. | Financial Conglomerates | President | |
| Albany Medical College | College/University | Undergraduate Degree | |
| Interstitial Cystitis Association of America, Inc. | Director/Board Member | ||
| ALLERGAN PLC | Pharmaceuticals: Major | Corporate Officer/Principal | |
First Principles Capital Management LLC
 First Principles Capital Management LLC Investment ManagersFinance First Principles Capital Management LLC (FPCM) is a registered investment advisor headquartered in New York City. The firm was founded in 2003 by Richard F. Dolan, Douglas A. Dachille and James H. van Epps. In 2015, they were acquired by AIG Capital Corp., a wholly owned subsidiary of American International Group, Inc. (NYSE: AIG). FPCM provides investment advisory and asset management services to affiliated and unaffiliated institutional clients. The firm provides customized separately managed accounts and targeted funds for endowments and foundations, financial institutions, corporations, pension funds, family offices, high net worth individuals, and trusts. | Investment Managers | Chief Executive Officer | |
| The University of Chicago Booth School of Business | College/University | Masters Business Admin | |
BridgeBio Pharma LLC
 BridgeBio Pharma LLC BiotechnologyHealth Technology BridgeBio Pharma LLC engages in the discovery and development of pharmaceutical drugs for patients with genetic diseases. It offers transthyretin stabilizer, SHP2 inhibitor, KRAS inhibitor, Collagen 7 replacement, and S1P-lyase inhibitor. The company was founded by Neil Kumar and is headquartered in Palo Alto, CA. | Biotechnology | Director/Board Member | |
| XORTX THERAPEUTICS INC. | Pharmaceuticals: Major | Director/Board Member | |
Sollis Therapeutics, Inc.
 Sollis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Sollis Therapeutics, Inc. is a clinical-stage specialty pharmaceutical company developing novel non-steroid and non-opioid analgesics. The company was founded by Gregory Fiore and Bryan Jones and is headquartered in Columbus, OH. | Pharmaceuticals: Major | Director of Finance/CFO | |
Bill & Melinda Gates Medical Research Institute
 Bill & Melinda Gates Medical Research Institute Miscellaneous Commercial ServicesCommercial Services The Bill & Melinda Gates Medical Research Institute is a non-profit organization based in Cambridge, MA. The institute focuses on programs aimed at reducing the burden of tuberculosis (TB), malaria, diarrheal diseases, and maternal, newborn, and child illnesses in low-and-middle-income countries (LMICs). Bill & Melinda Gates Medical Research Institute works through collaborating partners and organizations to develop and effectively use novel biomedical interventions to address substantial health concerns. Patrice Matchaba has been the CEO of the company since 2024. | Miscellaneous Commercial Services | Director/Board Member | |
| BRIDGEBIO PHARMA, INC. | Biotechnology | Director/Board Member | |
Gamida Cell, Inc.
 Gamida Cell, Inc. BiotechnologyHealth Technology Part of Gamida Cell Ltd., Gamida Cell, Inc. develops cellular and immune therapeutics. The company is based in Medfield, MA. The CEO of the company is Julian Adams. | Biotechnology | Director/Board Member | |
| AEROVATE THERAPEUTICS, INC. | Biotechnology | Director of Finance/CFO | |
| PROTARA THERAPEUTICS, INC. | Pharmaceuticals: Major | Director of Finance/CFO |
Statistiques
Internationale
| Etats-Unis | 32 |
| Canada | 3 |
| Royaume-Uni | 2 |
| Israël | 2 |
| Irlande | 2 |
Sectorielle
| Health Technology | 21 |
| Finance | 8 |
| Consumer Services | 8 |
| Commercial Services | 2 |
Opérationnelle
| Director/Board Member | 12 |
| Director of Finance/CFO | 11 |
| Corporate Officer/Principal | 7 |
| Undergraduate Degree | 4 |
| Treasurer | 4 |
Relations les plus connectées
| Insiders | |
|---|---|
| George Eldridge | 14 |
| Douglas Dachille | 12 |
| Abbey Jenkins | 12 |
| Jillian Moo-Young | 2 |
| Helene Madonick | 2 |
| Ashish Singh | 1 |
- Bourse
- Insiders
- Örn Almarsson
- Connexions Sociétés
